These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 34295722)
1. Comparison of bladder autoaugmentation by transurethral vesicomyotomy and hydrodistention for ketamine cystitis. Tan S; Zhu X; Zheng Z; Zheng L; Kang Y; Tang Z Transl Androl Urol; 2021 Jun; 10(6):2351-2361. PubMed ID: 34295722 [TBL] [Abstract][Full Text] [Related]
2. Augmentation enterocystoplasty is effective in relieving refractory ketamine-related bladder pain. Chung SD; Wang CC; Kuo HC Neurourol Urodyn; 2014 Nov; 33(8):1207-11. PubMed ID: 23996856 [TBL] [Abstract][Full Text] [Related]
3. Clinical Outcome of Augmentation Enterocystoplasty for Patients with Ketamine-induced Cystitis. Lee YK; Jhang JF; Kuo HC Pain Physician; 2017 Mar; 20(3):E431-E436. PubMed ID: 28339443 [TBL] [Abstract][Full Text] [Related]
4. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome. Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413 [TBL] [Abstract][Full Text] [Related]
5. The urodynamic characteristics and prognostic factors of patients with interstitial cystitis/bladder pain syndrome. Kuo YC; Kuo HC Int J Clin Pract; 2013 Sep; 67(9):863-9. PubMed ID: 23952465 [TBL] [Abstract][Full Text] [Related]
6. Is Urodynamic Study a Good Witness to the Progression of Ketamine-Associated Cystitis? Huang PW; Wu ST; Tsao CW; Tang SH; Cha TL; Sun GH; Yu DS; Chang SY; Meng E Low Urin Tract Symptoms; 2014 May; 6(2):98-102. PubMed ID: 26663548 [TBL] [Abstract][Full Text] [Related]
7. Intravesical hyaluronic acid therapy after bladder autoaugmentation by transurethral vesicomyotomy for ketamine cystitis: is it helpful? Tan S; Zhang L; Wang G; Zhu X; Tang Z World J Urol; 2022 Jun; 40(6):1597-1599. PubMed ID: 35249122 [No Abstract] [Full Text] [Related]
8. Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention. Zeng J; Lai H; Zheng D; Zhong L; Huang Z; Wang S; Zou W; Wei L J Int Med Res; 2017 Apr; 45(2):792-797. PubMed ID: 28415952 [TBL] [Abstract][Full Text] [Related]
9. Bladder autoaugmentation by vesicomyotomy in the pediatric neurogenic bladder. Stothers L; Johnson H; Arnold W; Coleman G; Tearle H Urology; 1994 Jul; 44(1):110-3. PubMed ID: 8042249 [TBL] [Abstract][Full Text] [Related]
10. Transurethral front-firing Greenlight bladder autoaugmentation for bladder contracture: technique and clinical outcomes. Bao JM; Tan WL; Wang BW; Qiu XF; Liu BC; Zhong RL; Li GY; Yang GS Int Urol Nephrol; 2016 Apr; 48(4):475-80. PubMed ID: 26803485 [TBL] [Abstract][Full Text] [Related]
11. Can the effect of adhesion barriers and/or intravesical balloon inflation improve bladder autoaugmentation outcomes in a rabbit model? Okutucu TM; Telli O; Ozturk E; Suer E; Hamidi N; Burgu B J Pediatr Urol; 2015 Apr; 11(2):86.e1-6. PubMed ID: 25869825 [TBL] [Abstract][Full Text] [Related]
12. Comparison of intravesical instillation of hyaluronic acid with intradetrusor botulinum toxin A injection or cystoscopic hydrodistention for ketamine-associated cystitis. Li B; Leng Q; Li C; Tan X; Su W; Li C J Int Med Res; 2020 Nov; 48(11):300060520973100. PubMed ID: 33259240 [TBL] [Abstract][Full Text] [Related]
13. Comparison of urodynamic results and quality of life between women with interstitial cystitis and overactive bladder. Hsu CC; Liang CC; Chang SD; Chien CW; Hsieh WC Taiwan J Obstet Gynecol; 2020 Jan; 59(1):39-42. PubMed ID: 32039798 [TBL] [Abstract][Full Text] [Related]
14. The Role of Immunoglobulin E in the Pathogenesis of Ketamine Related Cystitis and Ulcerative Interstitial Cystitis: An Immunohistochemical Study. Jhang JF; Hsu YH; Jiang YH; Kuo HC Pain Physician; 2016 May; 19(4):E581-7. PubMed ID: 27228524 [TBL] [Abstract][Full Text] [Related]
15. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome. Walker SJ; Zambon J; Andersson KE; Langefeld CD; Matthews CA; Badlani G; Bowman H; Evans RJ J Urol; 2017 Aug; 198(2):369-375. PubMed ID: 28202356 [TBL] [Abstract][Full Text] [Related]
16. Does detrusor underactivity affect the results of transurethral resection of prostate? Abdelhakim MA; Rammah A; Abozamel AH; El-Sheikh MG; Abdelazeem MS; Abdallah SM; Abdelaziz AY Int Urol Nephrol; 2021 Feb; 53(2):199-204. PubMed ID: 33074461 [TBL] [Abstract][Full Text] [Related]
17. Microvascular Injury in Ketamine-Induced Bladder Dysfunction. Lin CC; Lin AT; Yang AH; Chen KK PLoS One; 2016; 11(8):e0160578. PubMed ID: 27529746 [TBL] [Abstract][Full Text] [Related]
18. The effects of cystoscopy and hydrodistention on symptoms and bladder capacity in interstitial cystitis/bladder pain syndrome. Kirk PS; Santiago-Lastra Y; Qin Y; Stoffel JT; Clemens JQ; Cameron AP Neurourol Urodyn; 2018 Aug; 37(6):2002-2007. PubMed ID: 29566264 [TBL] [Abstract][Full Text] [Related]
19. Transurethral incision of congenital obstructive lesions in the posterior urethra in boys and its effect on urinary incontinence and urodynamic study. Nakamura S; Kawai S; Kubo T; Kihara T; Mori K; Nakai H BJU Int; 2011 Apr; 107(8):1304-11. PubMed ID: 20804485 [TBL] [Abstract][Full Text] [Related]
20. Urodynamically diagnosed detrusor hypocontractility: should transurethral resection of the prostate be contraindicated? Ou R; Pan C; Chen H; Wu S; Wei X; Deng X; Tang P; Xie K Int Urol Nephrol; 2012 Feb; 44(1):35-9. PubMed ID: 21660426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]